Hou, Feng-Qin <br/><br/>
Quantitative hepatitis B core antibody level is a new predictor for treatment response in HBeAg-positive chronic hepatitis B patients receiving peginterferon.  [electronic resource] 

 -  Theranostics  2015 
 - 218-26 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1838-7640 
<br/><br/><label>Standard No.: </label>10.7150/thno.10636  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--blood<br/>DNA, Viral--blood<br/>Drug Monitoring--methods<br/>Female<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Core Antigens--immunology<br/>Hepatitis B e Antigens--blood<br/>Hepatitis B, Chronic--diagnosis<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prognosis<br/>Viral Load<br/>Young Adult